Dimensional Fund Advisors
ANAC

Dimensional Fund Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Dimensional Fund Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-38,633
Closed -$2.06M – 3365
2016
Q1 		$2.06M Sell
38,633
-83,869
-68% -$6.19M ﹤0.01% 2757
2015
Q4 		$13.8M Buy
122,502
+10,224
+9% +$1.13M 0.01% 2047
2015
Q3 		$13.2M Buy
112,278
+7,498
+7% +$979K 0.01% 2051
2015
Q2 		$8.11M Buy
104,780
+19,836
+23% +$1.3M 0.01% 2375
2015
Q1 		$4.91M Buy
84,944
+43,011
+103% +$1.83M ﹤0.01% 2561
2014
Q4 		$1.35M Buy
41,933
+29,023
+225% +$871K ﹤0.01% 2942
2014
Q3 		$316K Sell
12,910
-11,581
-47% -$235K ﹤0.01% 3218
2014
Q2 		$434K Sell
24,491
-53,963
-69% -$869K ﹤0.01% 3210
2014
Q1 		$1.57M Buy
78,454
+5,764
+8% +$112K ﹤0.01% 2907
2013
Q4 		$1.22M Buy
+72,690
New +$1.01M ﹤0.01% 2989

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Dimensional Fund Advisors's ANAC Position: Q2 2016 in Review

Dimensional Fund Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 38,633 shares — an estimated $2.06M sold.

Dimensional Fund Advisors first reported a position in ANAC in Q4 2013 and held it in 10 quarters. The position peaked at $13.8M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Dimensional Fund Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Dimensional Fund Advisors sold 38,633 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.06M.
  • Dimensional Fund Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 10 quarters.
  • Dimensional Fund Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $13.8M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Dimensional Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.